Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Dtsch Med Wochenschr. 2013 Jan;138(1-2):43-5. doi: 10.1055/s-0032-1327370. Epub 2012 Dec 18.

[Biomarker screening for early detection of cancer].

[Article in German]

Author information

  • Klinik für Innere Medizin, Gastroenterologie und Onkologie, Oberschwabenklinik, St. Elisabeth, Ravensburg. guenther.wiedemann@oberschwabenklinikmann@oberschwabenklinik.de

Abstract

The question of when a certain concentration of a serum biomarker turns into a tumor marker, i. e. an objectively verifiable criterion for tumor diagnosis, leads to the analysis of the specificity (a measure of the proportion of correctly identified healthy individuals), sensitivity (a measure of the proportion of correctly recognized cancer patients), and precision (positive predictive value). Or in short: a tumor marker is specific if no healthy individual has one. This constitutes the problem: The serum concentrations of biomarkers of cancer patients and healthy subjects overlap. Healthy individuals occasionally have "tumor markers" and cancer patients in turn sometimes express inconspicuous biomarkers.

© Georg Thieme Verlag KG Stuttgart · New York.

PMID:
23250696
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Georg Thieme Verlag Stuttgart, New York
    Loading ...
    Write to the Help Desk